Delayed presentation of biopsy-proven eosinophilic myocarditis following COVID-19 mRNA vaccine

Chaitra Janga1, Tirth Patel1, Hussam Al Hennawi1

  • 1Department of Internal Medicine, Jefferson Abington Hospital, Abington, PA, USA.

Insights

Delayed eosinophilic myocarditis, a rare hypersensitivity reaction, can occur after COVID-19 mRNA vaccination. This case highlights a potential delayed presentation of this vaccine adverse event.

Area of Science:

  • Cardiology
  • Immunology
  • Vaccinology

Background:

  • Myopericarditis is an uncommon adverse reaction associated with COVID-19 mRNA vaccines, particularly in young males.
  • Eosinophilic myocarditis, a rare subtype of myocarditis, involves myocardial eosinophilic infiltrates and can be a hypersensitivity reaction to drugs or vaccines.
  • Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome may accompany eosinophilic myocarditis, which rarely involves myocyte necrosis or fibrosis.

Observation:

  • A case report details a 24-year-old male experiencing biopsy-proven eosinophilic myocarditis.
  • The patient's condition was likely a delayed adverse reaction following COVID-19 mRNA vaccination.

Findings:

  • This case represents the first reported instance of delayed eosinophilic myocarditis post-COVID-19 mRNA vaccination.
  • The patient presented with characteristic eosinophilic myocardial infiltrates.

Implications:

  • Clinicians should consider the possibility of delayed eosinophilic myocarditis as a vaccine adverse event.
  • Awareness of delayed presentations is crucial for timely diagnosis and management to prevent associated morbidity.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
10
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13